Edelman Joseph's Form 4 filing
Aldeyra Therapeutics, Inc. (ALDX) · filed Apr 8, 2024
- Accession no.
- 0001062993-24-008171
- Filed
- Apr 8, 2024, 5:32 PM ET
- Trade date
- Apr 4-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $833.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Common Stock | PPurchaseAcquired | +140,281 | $4.67 | +$655,112.27 | 9,238,139 | Indirect | |
| Apr 5, 2024 | Common Stock | PPurchaseAcquired | +37,712 | $4.74 | +$178,754.88 | 9,275,851 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.